Results 1 to 10 of about 4,559,139 (173)

Gut-Derived Protein-Bound Uremic Toxins [PDF]

open access: yesToxins, 2020
Chronic kidney disease (CKD) afflicts more than 500 million people worldwide and is one of the fastest growing global causes of mortality. When glomerular filtration rate begins to fall, uremic toxins accumulate in the serum and significantly increase ...
Amanda L. Graboski, Matthew R. Redinbo
doaj   +8 more sources

Adsorption- and Displacement-Based Approaches for the Removal of Protein-Bound Uremic Toxins [PDF]

open access: yesToxins, 2023
End-stage renal disease (ESRD) patients rely on renal replacement therapies to survive. Hemodialysis (HD), the most widely applied treatment, is responsible for the removal of excess fluid and uremic toxins (UTs) from blood, particularly those with low ...
Flávia S. C. Rodrigues, Mónica Faria
doaj   +7 more sources

Protein-Bound Uremic Toxins: New Insight from Clinical Studies [PDF]

open access: yesToxins, 2011
The uremic syndrome is attributed to the progressive retention of a large number of compounds which, under normal conditions, are excreted by healthy kidneys. The compounds are called uremic toxins when they interact negatively with biological functions.
Ziad A. Massy   +2 more
doaj   +6 more sources

The Medium Cut-Off Membrane Does Not Lower Protein-Bound Uremic Toxins [PDF]

open access: yesToxins, 2022
The accumulation of protein-bound uremic toxins (PBUT) is associated with increased cardiovascular outcomes in patients on dialysis. However, the efficacy of PBUT removal for a medium-cutoff (MCO) membrane has not been clarified.
Yang Gyun Kim   +8 more
doaj   +6 more sources

Protein-Bound Uremic Toxins in Senescence and Kidney Fibrosis [PDF]

open access: yesBiomedicines, 2023
Chronic kidney disease (CKD) is a progressive condition of kidney dysfunction due to diverse causes of injury. In healthy kidneys, protein-bound uremic toxins (PBUTs) are cleared from the systemic circulation by proximal tubule cells through the ...
Yi Yang   +2 more
doaj   +8 more sources

Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders [PDF]

open access: yesFrontiers in Endocrinology
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic clinical condition characterized by pathological and physiological interactions among metabolic abnormalities, chronic kidney disease, and cardiovascular diseases, leading to multi-organ ...
Shihan Zhang   +6 more
doaj   +6 more sources

Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients

open access: yesToxins, 2014
Chronic kidney disease (CKD) has been considered a major risk factor for cardiovascular diseases. Although great advances have recently been made in the pathophysiology and treatment of cardiovascular diseases, CKD remains a major global health problem ...
Shunsuke Ito, Masayuki Yoshida
doaj   +4 more sources

Strategies for Removal of Protein-Bound Uremic Toxins in Hemodialysis [PDF]

open access: yesToxins
The removal of protein-bound uremic toxins (PBUTs) from the blood of kidney failure patients with conventional dialysis is limited. However, as their harmful effects and association with morbidity and mortality in dialysis patients are increasingly ...
Joost C. de Vries   +9 more
doaj   +4 more sources

Comparable Efficacy of Medium Cut-Off Dialysis Plus HA130 Hemoadsorption and Postfilter Hemodiafiltration in Removing Protein-Bound Uremic Toxins [PDF]

open access: yesKidney Medicine
Rationale & Objective: Protein-bound uremic toxins, including indoxyl sulfate and p-cresyl sulfate, are poorly removed by conventional dialysis and contribute to cardiovascular, inflammatory, and neurological complications in end-stage kidney disease.
Gonzalo Ramírez-Guerrero   +8 more
doaj   +2 more sources

Effect of Low Protein Diet Supplemented with Ketoanalogs on Endothelial Function and Protein-Bound Uremic Toxins in Patients with Chronic Kidney Disease [PDF]

open access: yesBiomedicines, 2023
Studies have demonstrated that a low-protein diet supplemented with ketoanalogs (KAs) could significantly retard progression of renal function in patients with chronic kidney disease (CKD) stages 3–5.
George Chang   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy